PCLS Acquires MultiGen Dx Assets | GenomeWeb

NEW YORK (GenomeWeb News) – Specialty laboratory Physician's Choice Laboratory Services today announced it has acquired the assets of MultiGen Diagnostics for an undisclosed amount.

The deal includes full access to and control of the commercialization of MultiGen's platform technology, which PCLS said "greatly reduces the cost of delivering targeted molecular diagnostics and genetic mutation analysis."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.